GigaGen

About:

GigaGen specialized in the early discovery and development of recombinant biotherapeutic medicines.

Website: http://www.gigagen.com/

Twitter/X: gigageninc

Top Investors: National Science Foundation, Grifols

Description:

GigaGen is advancing a pipeline of first-in-class biotherapeutics, including novel oncology antibody drug combinations and the world’s first recombinant polyclonal hyperimmune gammaglobulin. Behind our diverse and growing pipeline is a mission to bring forth a new generation of highly efficacious drugs, driven by an unparalleled understanding of immune dysregulation. Our proprietary antibody discovery technology quickly characterizes every cell in complex immune systems, powering our selection of drug targets, identification of drug candidates and preclinical assessment of efficacy.